Company News in the Life Science Industry

HONG KONG, June 21, 2018 /PRNewswire/ -- Prosten Health Holdings Limited ("the Company"; Stock code: 08026) is pleased to announce the Company has officially renamed as "China Brilliant Global Limited" (referred to as "China Brilliant") with effect from 20 June 2018.

SINGAPORE, June 21, 2018 /PRNewswire/ -- Adverse patient safety events in the US and Western European healthcare systems impose an estimated cost burden of US$ 317.93 billion in 2016 and is estimated to increase at a CAGR of 3.2% reaching US$ 383.7 billion in 2022. The rising incidences of adverse... Read more ››

LUND, Sweden, June 21, 2018 /PRNewswire/ --

GÖTHENBURG, Sweden, June 21, 2018 /PRNewswire/ -- The Board of Directors of Capio AB has today appointed Attila Vegh as the new President and CEO for Capio AB. He is currently CEO of Penta Hospitals International, the leading hospital chain in Central and Eastern Europe. Attila Vegh will... Read more ››

STOCKHOLM, June 21, 2018 /PRNewswire/ -- The previously announced breakthrough update to Nevisense, SciBase device for the early detection of melanoma, has now been released.

EVANSTON, Ill., June 20, 2018 /PRNewswire/ -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the pricing of its initial public offering of 6,399,999 shares of its common stock at... Read more ››

NEW BRUNSWICK, N.J., June 20, 2018 /PRNewswire/ -- Ramzan M. Zakir, M.D., F.A.CC., FSCAI is recognized by Continental Who's Who as 2018 Cardiologist of The Year in the field of Medicine in recognition of his role as Interventional Cardiologist at Heart & Vascular Institute of Central New... Read more ››

SOUTH SAN FRANCISCO, Calif., June 20, 2018 /PRNewswire/ -- Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, announced today that it has priced its initial... Read more ››

LONDON, June 20, 2018 /PRNewswire/ -- The nuclear medicine market is projected to grow at a CAGR of 5.9%
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac... Read more ››

DUBLIN, June 20, 2018 /PRNewswire/ --

Agreement supports development and availability of an affordable, high-quality enzyme deficiency test